UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.342-348

2018

Volltextzugriff (PDF)

A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

British journal of pharmacology, 2012-06, Vol.166 (3), p.1097-1113

2012

Volltextzugriff (PDF)

Development of Irreversible Diphenyl Phosphonate Inhibitors for Urokinase Plasminogen Activator

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2411-2413

2004

Volltextzugriff (PDF)

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.2057-2069

2018

Volltextzugriff (PDF)

Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction

Journal of thrombosis and haemostasis, 2015-12, Vol.13 (12), p.2227-2232

2015

Volltextzugriff (PDF)

The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors

Current medicinal chemistry, 1999-04, Vol.6 (4), p.311-327

1999

Volltextzugriff (PDF)

Structure−Activity Relationship of Diaryl Phosphonate Esters as Potent Irreversible Dipeptidyl Peptidase IV Inhibitors

Journal of medicinal chemistry, 1999-03, Vol.42 (6), p.1041-1052

1999

Volltextzugriff (PDF)

Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5)

Journal of immunological methods, 1996-01, Vol.189 (1), p.99-105

1996

Volltextzugriff (PDF)

Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family

The Journal of biological chemistry, 2001-08, Vol.276 (32), p.29839-29845

2001

Volltextzugriff (PDF)

Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power

Protein engineering, 1999-03, Vol.12 (3), p.243-250

1999

Volltextzugriff (PDF)

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

Blood, 2001-12, Vol.98 (13), p.3554-3561

2001

Volltextzugriff (PDF)

ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain

Matrix biology, 2009-04, Vol.28 (3), p.160-169

2009

Volltextzugriff (PDF)

Arginine residues as stabilizing elements in proteins

Biochemistry (Easton), 1992-03, Vol.31 (8), p.2239-2253

1992

Volltextzugriff (PDF)

Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury

Experimental lung research, 2016-07, Vol.42 (6), p.277-285

2016

Volltextzugriff (PDF)

Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion

FEBS letters, 2001-11, Vol.507 (3), p.327-330

2001

Volltextzugriff (PDF)

Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction

The Journal of biological chemistry, 1999-02, Vol.274 (7), p.3988-3993

1999

Volltextzugriff (PDF)

Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin A by dipeptidyl peptidase IV using high-performance liquid chromatography/electrospray mass spectrometry

Journal of mass spectrometry., 1999-04, Vol.34 (4), p.255-263

1999

Volltextzugriff (PDF)

Pyrrolidides: synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV

European journal of medicinal chemistry, 1997, Vol.32 (4), p.301-309

1997

Volltextzugriff (PDF)

Spectral properties of the higher oxidation states of prostaglandin H synthase

The Journal of biological chemistry, 1985-12, Vol.260 (28), p.14894-14896

1985

Volltextzugriff (PDF)

Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides

European journal of biochemistry, 2000-09, Vol.267 (17), p.5608-5613

2000

Volltextzugriff (PDF)

Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties

Thrombosis and haemostasis, 1995-08, Vol.74 (2), p.646-654

1995

Volltextzugriff (PDF)

The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes

Proteins, structure, function, and bioinformatics, 1991-01, Vol.10 (1), p.50-69

1991

Volltextzugriff (PDF)

3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)

Atherosclerosis, 2020-12, Vol.315, p.e87-e87

2020

Volltextzugriff (PDF)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

World journal of gastroenterology : WJG, 2016-12, Vol.22 (47), p.10275-10286

2016

Volltextzugriff (PDF)

In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (prodipine)

Biochemical pharmacology, 1997-07, Vol.54 (1), p.173-179

1997

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(99)

Sprache

Englisch
(99)
Japanisch
(16)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction

A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

Development of Irreversible Diphenyl Phosphonate Inhibitors for Urokinase Plasminogen Activator

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction

The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors

Structure−Activity Relationship of Diaryl Phosphonate Esters as Potent Irreversible Dipeptidyl Peptidase IV Inhibitors

Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5)

Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family

Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain

Arginine residues as stabilizing elements in proteins

Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury

Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion

Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction

Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin A by dipeptidyl peptidase IV using high-performance liquid chromatography/electrospray mass spectrometry

Pyrrolidides: synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV

Spectral properties of the higher oxidation states of prostaglandin H synthase

Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides

Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties

The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes

3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (prodipine)

Suchergebnisse filtern